KOL

KOL (Key Opinion Leaders)

speaker

KOL Engagement and Planning, KOL Opinion, KOL Insights Primary Market Research, Rare Disease Research & Knowledge

Thelansis has strong expertise in identifying, mapping, segmenting, and profiling KOLs across therapy areas to collect the most relevant KOL Insights/ KOL opinions. From the beginning of the product development process, KOL engagement is the key success factor in Rare and ultra-rare indications. Global KOL Panel Management System; comprises directories of trial investigators, Researchers, Healthcare practitioners (HCPs), Payers, Regulatory bodies, and speakers.

Successful KOL identification is about identifying anyone with the potential to impact your work – clinicians, authors, speakers, nurses, tweeters, or the medics building cutting-edge apps for their patients.

We’re confident in our ability & accuracy to identify the right people because we’ve spent years engineering every step of the KOL identification process and transforming what ‘KOL identification’ can do for you.

We also appreciate that our work is all about people. That’s why even the world’s most enormous bucket of accurate analytics cannot circumvent the subjective nuances of KOL identification and influence.

So, whether your KOL identification requires a global program, a national exercise, or an exploration of tomorrow’s emerging markets, we can help because KOL identification is what we do every day.

Clinical trial analytics, Clinical trial landscape, Rare disease research, Rare disease knowledge, KOL engagement

KOL mapping involves mapping the entire Expert/KOL landscape as a whole — essential because you can’t validate an individual Expert in isolation from their peer group or without consideration of the overall context.

KOL mapping can also map the entire “KOL pyramid” — essential to help you identify, understand, and engage with every single segmented layer — each with its requirements.

But beware — the KOL pyramid identified through KOL mapping today, say a few years pre-launch, will not be the same as you get to launch. The pyramid often “flips” so that the front-line HCPs at the original pyramid’s lower rungs now rise to the top as they become your most important customers and new KOLs. These are people who will directly impact the uptake of your asset post-launch.

Our ongoing systematic and analytical KOL mapping programs can help map all of this.

Our KOL mapping can also help you see the connections, collaborations, and networks within a community of experts, giving you a complete contextual picture of the Expert/KOL landscape — a canvas on which to create your own unique KOL programs.

When you know your KOLs well, all you may need is an unbiased sense-check to quickly and efficiently validate your current list.

Similarly, when you have been in a therapy area for a while, you may get used to repeatedly working with the same people. As a result, you don’t always notice the changes occurring just outside your field of vision — myopia from over-confidence and over-familiarity sets in.

That’s where KOL validation can help.

You provide us with a list of KOLs, and we will augment, segment, refresh, and validate them using multiple research methodologies.

Our KOL validation can tell you the three most important things you need to know — who should stay, who should go, and who should be added — to help keep your KOL lists fully up to date and relevant for your strategic and tactical needs.

Beyond the top KOLs, who are the rising stars, the emerging Experts? And what about the more distant “faint signals” — the people you should be actively looking for?

And we don’t just mean clinicians when we say “rising stars.” Even a newly active YouTuber in a rare disease represents an emerging Expert – someone to keep an eye on.

Identifying, mapping, and tracking the next generation of experts and rising stars is never easy — things change, ideas come and go, people come and go…

Nonetheless, given the long development cycle of medicines and devices, identifying, understanding, and engaging rising stars, emerging Experts, and the next generation of KOLs is critical.

We have the processes, methodologies, and patience to assist you in identifying rising stars and looking beyond the present so that when the future arrives, you are fully prepared.

Digital KOLs are a different breed, with further communication and engagement patterns that necessitate an entirely new set of methodologies and tools to identify and map.

To start with, digital KOLs require you to go beyond simple identification and look at more advanced segmentation and phenotyping based on an individual’s digital characteristics and propensity for online interactions (e.g., data multiplier, content creator, opinion former, proactive educator, etc.).

Analyzing the digital KOL mindset is also essential when creating engagement plans — what is their online view on key therapeutic issues, and what topics within your therapy area are the most vocal about online?

And finally, given the dynamic nature of the online realm, it’s essential to activate real-time monitoring of crucial influencer activity to help identify acute opportunities for digital KOLs in online discussions.

Our range of digital KOL services helps you navigate all the above facets of this brave new world —identification, analytics, segmentation, phenotyping, mindset, influencer monitoring, and digital KOL landscape mapping — without forgetting that the traditional underlying principles of thought leadership, expertise, and human influence still apply.

Collaborative groups, co-operative groups, clinical trial groups, and clinical collectives are known by many names. The importance of such groups in designing, supporting, and running clinical trial programs is no doubt.

We can help you identify, map, and understand the Co-operative Group landscape with unparalleled detail. Who are the most important groups, which indications and molecules are they focussing on, and what practice-changing trials are they responsible for?

Our profiles give you all the details you need to monitor, segment, and prioritize your Co-operative Group engagements – disease state activity, study type metrics, study phase analysis, drugs investigated, collaborations with KOLs, publications, and other outputs, trialists, and collaborators involved, and much more.

A “stakeholder” is simply an entity or voice with the power to impact the success of your medicine. And effective stakeholder mapping helps you take a holistic approach to stakeholder engagement.

Stakeholder mapping gives you:
The people — KOLs, Nurse Practitioners, Patient Advocates, Regional Experts, Physicians, Speakers…

The places — Centers of Excellence, Treatment Centres, Trial Centres, Referral Centres…

The organizations — Professional Medical Organisations, Patient Organisations, Advocacy Groups, Payor Groups, Independent Funding Bodies, NGOs…

Stakeholder mapping ensures that all your stakeholders, influencers, networks, and voices are identified, mapped, and profiled, all in one place.

Our speaker mapping service can help you optimize your identification and selection of speakers to meet all your strategic and communication needs.

To identify, profile, and give you the most comprehensive and accurate speaker map possible, our speaker mapping service involves multiple research methodologies, including speaker activity analysis, audience research, and 1-to-1 discussions with leading speakers.

We curate all these inputs to map the speaker landscape and make solid recommendations about which you can feel completely confident.

Speaker mapping gives you all the insights (and digital tools) you need to understand the speaker landscape, assemble a group of influential speakers, and consistently select the right speaker for your topics, audiences, and events.

Our speaker mapping service hands all of this to you on a plate, driven by evidence, with the highest level of compliance and confidence.

A small treatment center pioneering a relatively new diagnostic biomarker may not be a traditional “center of excellence.” However, it may be a center of importance to your success.

Likewise, a fellowship training program may not be the world’s most renowned “center of excellence.” However, the emerging Experts coming out of that center, all sharing the same thinking and approach to management, may be necessary for your work.

Going beyond the center of excellence mapping, we can tell you about a wide range of important institutions — clinical trial sites, tertiary referral centers, primary-care management groups in sparsely populated regions, R&D powerhouses, and hospitals focusing on technology.

Identifying and mapping all such centers also requires us to go beyond traditional identification methods such as those used when mapping more established centers of excellence because these tend to have traits that are easily identifiable and quantifiable, e.g., analyzing high-value publication outputs, looking for the presence of KOLs, assessing established reputations, etc.